Skip to main content
Log in

Association between hemoglobin A1c trajectory during pregnancy and adverse birth outcomes among non-gestational diabetic women

  • Original Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

Aims

Previous studies have shown that higher hemoglobin A1c (HbA1c) levels within the normal range during pregnancy can increase the risk of adverse birth outcomes. However, the effects of the longitudinal HbA1c trajectory during pregnancy on adverse birth outcomes among non-gestational diabetic women are poorly characterized. We aimed to identify HbA1c trajectory during pregnancy among non-gestational diabetic women and to estimate their associations with adverse birth outcomes.

Methods

Data was extracted from the Information System of Guangdong Women and Children Hospital, China, from January 2017 to July 2022. This study involved 13,979 women who did not have gestational diabetes mellitus and underwent repeated HbA1c measurements during pregnancy. Latent mixture modeling was used to identify HbA1c trajectory groups. Logistic regression was applied to explore the associations between HbA1c trajectory groups and adverse birth outcomes, including preterm delivery, low birth weight, macrosomia, small for gestational age, and large for gestational age (LGA).

Results

Three HbA1c trajectory groups were identified: low-stable (range 4.0% [20 mmol/mol]–4.4% [25 mmol/mol]), moderate-stable (range 4.6% [27 mmol/mol]–5.1% [32 mmol/mol]), and elevated-increasing (range 5.0% [31 mmol/mol]–5.6% [38 mmol/mol]). Compared with the low-stable HbA1c group, the elevated-increasing group had a higher risk of preterm delivery and LGA. The adjusted OR (95% CIs) were 1.67 (1.13, 2.49) and 1.47 (1.01, 2.12) for preterm delivery and LGA, respectively.

Conclusions

Among non-gestational diabetic women, the elevated-increasing HbA1c trajectory group was associated with a higher risk of preterm delivery and LGA. This finding emphasizes the importance of maintaining optimal HbA1c levels throughout pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Ye W, Luo C, Huang J et al (2022) Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. BMJ 377:e67946. https://doi.org/10.1136/bmj-2021-067946

    Article  Google Scholar 

  2. Bianco ME, Kuang A, Josefson JL et al (2021) Hyperglycemia and adverse pregnancy outcome follow-up study: newborn anthropometrics and childhood glucose metabolism. Diabetologia 64(3):561–570. https://doi.org/10.1007/s00125-020-05331-0

    Article  CAS  PubMed  Google Scholar 

  3. Farrar D, Simmonds M, Bryant M et al (2016) Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis. BMJ 354:i4694. https://doi.org/10.1136/bmj.i4694

    Article  PubMed  PubMed Central  Google Scholar 

  4. Li K, Li X, Morse AN et al (2022) Residual risk associations between initial hyperglycemia and adverse pregnancy outcomes in a large cohort including 6709 women with gestational diabetes. Diabetes Metab 48(1):101320. https://doi.org/10.1016/j.diabet.2022.101320

    Article  PubMed  Google Scholar 

  5. Sert UY, Ozgu-Erdinc AS (2021) Gestational diabetes mellitus screening and diagnosis. Adv Exp Med Biol 1307:231–255. https://doi.org/10.1007/5584_2020_512

    Article  CAS  PubMed  Google Scholar 

  6. Sacks DB, Arnold M, Bakris GL et al (2023) Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 69(8):808–868. https://doi.org/10.1093/clinchem/hvad080

    Article  PubMed  Google Scholar 

  7. Jarrett RJ, Murrells TJ, Shipley MJ et al (1984) Screening blood glucose values: effects of season and time of day. Diabetologia 27(6):574–577. https://doi.org/10.1007/BF00276970

    Article  CAS  PubMed  Google Scholar 

  8. Goldstein DE (1984) Is glycosylated hemoglobin clinically useful? N Engl J Med 310(6):384–385. https://doi.org/10.1056/NEJM198402093100609

    Article  CAS  PubMed  Google Scholar 

  9. Nathan DM, Kuenen J, Borg R et al (2008) Translating the A1C assay into estimated average glucose values. Diabetes Care 31(8):1473–1478. https://doi.org/10.2337/dc08-0545

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Rohlfing CL, Wiedmeyer HM, Little RR et al (2002) Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the diabetes control and complications trial. Diabetes Care 25(2):275–278. https://doi.org/10.2337/diacare.25.2.275

    Article  CAS  PubMed  Google Scholar 

  11. World Health Organization (2011) Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus: abbreviated report of a WHO consultation. World Health Organization, Geneva

    Google Scholar 

  12. O’Connor C, O’Shea PM, Owens LA et al (2011) Trimester-specific reference intervals for haemoglobin A1c (HbA1c) in pregnancy. Clin Chem Lab Med 50(5):905–909. https://doi.org/10.1515/CCLM.2011.397

    Article  CAS  PubMed  Google Scholar 

  13. Mosca A, Paleari R, Dalfrà MG et al (2006) Reference intervals for hemoglobin A1c in pregnant women: data from an Italian multicenter study. Clin Chem 52(6):1138–1143. https://doi.org/10.1373/clinchem.2005.064899

    Article  CAS  PubMed  Google Scholar 

  14. Bozkurt L, Göbl CS, Leitner K et al (2020) HbA1c during early pregnancy reflects beta-cell dysfunction in women developing GDM. BMJ Open Diabetes Res Care 8(2):1. https://doi.org/10.1136/bmjdrc-2020-001751

    Article  Google Scholar 

  15. Bi J, Ji C, Wu Y et al (2020) Association between maternal normal range HbA1c values and adverse birth outcomes. J Clin Endocrinol Metab 105(6):1. https://doi.org/10.1210/clinem/dgaa127

    Article  Google Scholar 

  16. Carlsen EØ, Harmon Q, Magnus MC et al (2022) Glycated haemoglobin (HbA1c) in mid-pregnancy and perinatal outcomes. Int J Epidemiol 51(3):759–768. https://doi.org/10.1093/ije/dyab270

    Article  PubMed  PubMed Central  Google Scholar 

  17. Edelson PK, James KE, Leong A et al (2020) Longitudinal changes in the relationship between hemoglobin A1c and glucose tolerance across pregnancy and postpartum. J Clin Endocrinol Metab 105(5):e1999–e2007. https://doi.org/10.1210/clinem/dgaa053

    Article  PubMed  PubMed Central  Google Scholar 

  18. Hughes RC, Rowan J, Florkowski CM (2016) Is there a role for HbA1c in pregnancy? Curr Diab Rep 16(1):5. https://doi.org/10.1007/s11892-015-0698-y

    Article  CAS  PubMed  Google Scholar 

  19. Hughes RC, Moore MP, Gullam JE et al (2014) An early pregnancy HbA1c ≥ 5.9% (41 mmol/mol) is optimal for detecting diabetes and identifies women at increased risk of adverse pregnancy outcomes. Diabetes Care 37(11):2953–2959. https://doi.org/10.2337/dc14-1312

    Article  CAS  PubMed  Google Scholar 

  20. Lowe LP, Metzger BE, Dyer AR et al (2012) Hyperglycemia and adverse pregnancy outcome (HAPO) study: associations of maternal A1C and glucose with pregnancy outcomes. Diabetes Care 35(3):574–580. https://doi.org/10.2337/dc11-1687

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Nagin DS (2014) Group-based trajectory modeling: an overview. Ann Nutr Metab 65(2–3):205–210. https://doi.org/10.1159/000360229

    Article  CAS  PubMed  Google Scholar 

  22. Metzger BE, Gabbe SG, Persson B et al (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33(3):676–682. https://doi.org/10.2337/dc09-1848

    Article  CAS  PubMed  Google Scholar 

  23. Li MF, Ma L, Yu TP et al (2020) Adverse maternal and neonatal outcomes in pregnant women with abnormal glucose metabolism. Diabetes Res Clin Pract 161:108085. https://doi.org/10.1016/j.diabres.2020.108085

    Article  CAS  PubMed  Google Scholar 

  24. Barbry F, Lemaitre M, Ternynck C et al (2022) HbA1c at the time of testing for gestational diabetes identifies women at risk for pregnancy complications. Diabetes Metab 48(3):101313. https://doi.org/10.1016/j.diabet.2021.101313

    Article  CAS  PubMed  Google Scholar 

  25. Chehab RF, Ferrara A, Greenberg MB et al (2022) Glycemic control trajectories and risk of perinatal complications among individuals with gestational diabetes. JAMA Netw Open 5(9):e2233955. https://doi.org/10.1001/jamanetworkopen.2022.33955

    Article  PubMed  PubMed Central  Google Scholar 

  26. Rafat D, Ahmad J (2012) HbA1c in pregnancy. Diabetes Metab Syndr 6(1):59–64. https://doi.org/10.1016/j.dsx.2012.05.010

    Article  PubMed  Google Scholar 

  27. Metzger BE, Lowe LP, Dyer AR et al (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358(19):1991–2002. https://doi.org/10.1056/NEJMoa0707943

    Article  PubMed  Google Scholar 

  28. Worth R, Potter JM, Drury J et al (1985) Glycosylated haemoglobin in normal pregnancy: a longitudinal study with two independent methods. Diabetologia 28(2):76–79. https://doi.org/10.1007/BF00279919

    Article  CAS  PubMed  Google Scholar 

  29. Hiramatsu Y, Shimizu I, Omori Y et al (2012) Determination of reference intervals of glycated albumin and hemoglobin A1c in healthy pregnant Japanese women and analysis of their time courses and influencing factors during pregnancy. Endocr J 59(2):145–151. https://doi.org/10.1507/endocrj.k10e-410

    Article  CAS  PubMed  Google Scholar 

  30. Sánchez-González CM, Castillo-Mora A, Alvarado-Maldonado IN et al (2018) Reference intervals for hemoglobin A1c (HbA1c) in healthy Mexican pregnant women: a cross-sectional study. BMC Pregnancy Childbirth 18(1):424. https://doi.org/10.1186/s12884-018-2057-x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study was supported by the National Natural Science Foundation of China (82073660, 82003479) and China Postdoctoral Science Foundation (2019M662646, 2020T130220).

Author information

Authors and Affiliations

Authors

Contributions

JP and LZ conceived the study and drafted the manuscript. GJF and GCL critically reviewed the manuscript. All authors provided substantial contributions to the interpretation of data, made critical revisions to the manuscript and approved the final manuscript.

Corresponding authors

Correspondence to Gaojie Fan or Guocheng Liu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval

This study was conducted following the Helsinki Declaration, and the study protocol was approved by the ethics committee of the Guangdong Women and Children Hospital (Approval Number 202201203).

Informed consent

As all data used in this study was de-identified, no written informed consent was obtained.

Additional information

Managed By Annunziata Lapolla.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 48 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peng, J., Zhang, L., Zheng, L. et al. Association between hemoglobin A1c trajectory during pregnancy and adverse birth outcomes among non-gestational diabetic women. Acta Diabetol (2024). https://doi.org/10.1007/s00592-024-02283-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00592-024-02283-4

Keywords

Navigation